The field of nanomedicine is a complex and rapidly growing scientific domain. Nanomedicine encompasses a large and diverse number of pharmaceutical formulations including liposomes, micelles, nanoparticles and polymer-drug conjugates. In this second podcast on nanomedicines, pharmacists will be provided with examples of nanomedicines, their challenges, formulary considerations, and future.
SPEAKERS
Tamer Elbayoumi, PhD, MS, RPh is a professor of pharmaceutical sciences. He completed his Fellowship at the Center of Pharmaceutical Biotechnology and Nanomedicine after receiving his Ph.D. in Pharmaceutical Sciences from Northeastern University, Boston. Before joining Midwestern University, he worked as senior formulation research scientist at Atrium Medical/ Getinge Corp. Dr. Elbayoumi has authored numerous publications, focusing on nanomedicines and targeted nanocarrier delivery systems in the areas of translational cardiovascular therapy, investigational cancer chemotherapy, and diagnostic imaging.
John B. Hertig, PharmD, MS, CPPS is associate professor of pharmacy practice in the Butler University College of Pharmacy and Health Sciences where he works to enhance the safety of the medication use process, while using evidence to inform patient advocacy efforts. Dr. Hertig is a Member of the United States Food and Drug Administration Drug Safety and Risk Management Advisory Committee and as is President of the Board of Directors for the Alliance for Safe Online Pharmacies.
Elizabeth (Liz) Shlom, PharmD, MBA, BCPS is vice president, Acurity Clinical Pharmacy Program at Premier, Inc. In her role at Premier, Liz coordinates monthly ACPE-accredited educational forums, a weekly newsletter, drug information research assistance, membership surveys and website-based publications on clinically relevant topics including cost-saving initiatives and drug shortage alternatives. She served as NYSCHP President, NYS Delegate to the ASHP House of Delegates, and has served on the ASHP Council of Public Policy, and is currently on the Emerging Sciences Section Advisory Group.